TP53 and KRAS were also identified as the significantly mutated genes in a cohort of ICC patients and Ras/PI3K signaling was one of the most affected pathways, followed by cell cycle signaling pathway [22]. This evidence concerns the gene TP53 and intrahepatic cholangiocarcinoma.